Microdosing Psychedelics to Improve Mood

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 15, 2023

Primary Completion Date

December 21, 2024

Study Completion Date

August 31, 2025

Conditions

Major Depressive Disorder

Interventions

DRUG

Psilocybin first

Participants will receive 8 doses of 2mg psilocybin.

DRUG

Placebo first

Participants will receive 4 doses of placebo followed by 4 doses of 2mg psilocybin

Trial Locations (1)

Psych Research, Toronto